Kombinationspräparat aus Vitamin-D-Metaboliten oder Vitamin-D-Analoga und einer östrogenen Komponente zur Behandlung von Osteoporose

摘要

Disclosed is a compound preparation wherein the bone cell activator is a vitamin D metabolite or vitamin D analogue and the resorption inhibitor is an oestrogenic compound. The inventive compound preparation is used in a therapeutical plan which comprises one or more cycles. Each cycle consists of the following steps: a) daily administration of a vitamin D metabolite or vitamin D analogue during 1-7 days, b) daily administration of an oestrogenic compound during 21-120 days after a) or after an interphase of up to 30 days.